IBRX
ImmunityBio Inc.
$2.49
+$0.13(+5.51%)
39
Overall
40
Value
40
Tech
39
Quality
Market Cap
$2.36B
Volume
9.60M
52W Range
$1.83 - $7.48
Target Price
$10.20
EPS Estimates Overview
| Current Quarter | $-0.1 | Next Quarter | $-0.11 |
| Current Year | $-0.46 | Next Year | $-0.37 |
| QoQ Growth | -10.0% | YoY Growth | +19.6% |
| 3Y EPS CAGR | +12.8% | Target Price | $10.20 |
| Consensus | Buy | Upside | +309.6% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IBRX | $2.49 | +5.5% | 9.60M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |